US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Scienture Holdings, Inc.

1.59

0.0000

Volume:96.93K

Turnover:154.04K

Market Cap:20.86M

PE:-0.57

High:1.62

Open:1.62

Low:1.53

Close:1.59

Loading ...

Overview Company News Filings

Scienture Holdings Inc - Proposed Deal for Total Consideration of $5 Mln

THOMSON REUTERS

Scienture Announces the Divestiture of Its Legacy Subsidiaries for a Total Consideration of $5 Million and Dedicates Its Full Focus to the Branded and Specialty Pharma Segment Through Scienture, Llc.

THOMSON REUTERS

SCIENTURE announces the divestiture of its legacy subsidiaries for a total consideration of $5 million and dedicates its full focus to the Branded and Specialty Pharma segment through Scienture, LLC.

BRIEF-Scienture Holdings Files Prospectus Relates To Resale From Time To Time Of Up To 2.6 Million Shares Of Common Stock By Selling Stockholders

Scienture files to sell 2.64M shares of common stock for holders

Scienture CEO says focused on execution, growth, expansion for years ahead

Scienture Holdings, Inc. Issues Annual Letter to Shareholders

Scienture appoints Rath as CCO, enters agreement with Syneos

SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization

Scienture announces draaw on Equity Line of Credit

Scienture Holdings Inc - to Launch Arbli in U.S. in Q3 2025

THOMSON REUTERS

Scienture Holdings Announces Draw on Eloc, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days

THOMSON REUTERS

Scienture Says US FDA Approves Oral Liquid Formulation of Hypertension Drug Losartan

MT Newswires Live

Scienture Announces the U.S. FDA Approval of Its Nda for Scn-102, to Be Launched as Arblitm, (Losartan Potassium) Oral Suspension, 10Mg/Ml. the Global Market for Losartan Potassium Was Approximately $1.5 Billion in Sales in 2024.

THOMSON REUTERS

Scienture Holdings Inc - Arbli Expected to Be Available in U.S. in Q3 2025

THOMSON REUTERS

Scienture Holdings Inc - Appoints Eric Sherb as CFO

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-CoreCivic, Teladoc, Dynavax

Scienture Unit, Summit Biosciences Collaborate to Launch Naloxone Spray for Opioid Overdose Treatment in the US

MT Newswires Live

Scienture Holdings Shares up 45.7% on Launch of Opioid Overdose Antidote Rezenopy

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Scienture, ARS Pharma, BrightSpring Health

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SCNX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCNX\",,,,,undefined,":{"symbol":"SCNX","market":"US","secType":"STK","nameCN":"Scienture Holdings, Inc.","latestPrice":1.59,"timestamp":1752507043924,"preClose":1.59,"halted":0,"volume":96929,"delay":0,"floatShares":8842128,"shares":13116429,"eps":-2.796662,"marketStatus":"Trading","change":0,"latestTime":"07-14 11:34:58 EDT","open":1.62,"high":1.62,"low":1.5298,"amount":154036.6880087,"amplitude":0.05673,"askPrice":1.63,"askSize":700,"bidPrice":1.59,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-2.796662,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1752523200000},"marketStatusCode":2,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":1.59,"preHourTrading":{"tag":"盘前","latestPrice":1.65,"preClose":1.59,"latestTime":"09:25 EDT","volume":3607,"amount":5876.190391800001,"timestamp":1752499532777},"postHourTrading":{"tag":"盘后","latestPrice":1.5901,"preClose":1.59,"latestTime":"19:35 EDT","volume":14381,"amount":22913.825,"timestamp":1752276957214},"volumeRatio":1.421002},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCNX\",,,,,undefined,":{"symbol":"SCNX","floatShares":8842128,"roa":"-14.99%","roe":"-35.92%","lyrEps":2.685903,"volumeRatio":1.421002,"shares":13116429,"dividePrice":0,"high":1.62,"amplitude":0.05673,"preClose":1.59,"low":1.5298,"week52Low":0.69,"pbRate":"0.26","psRate":"141.97","week52High":23.77,"institutionHeld":0,"latestPrice":1.59,"committee":-0.985816,"eps":-2.796662,"divideRate":0,"volume":96929,"delay":0,"ttmEps":-2.796662,"open":1.62,"prevYearClose":6.05,"prevWeekClose":1.59,"prevMonthClose":1.04,"prevQuarterClose":1.04,"fiveDayClose":1.62,"twentyDayClose":1.115,"sixtyDayClose":0.937},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SCNX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525993998","title":"Scienture Holdings Inc - Proposed Deal for Total Consideration of $5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2525993998","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525993998?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:05","pubTimestamp":1744113906,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM1XI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2525289939","title":"Scienture Announces the Divestiture of Its Legacy Subsidiaries for a Total Consideration of $5 Million and Dedicates Its Full Focus to the Branded and Specialty Pharma Segment Through Scienture, Llc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2525289939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525289939?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:05","pubTimestamp":1744113906,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM1XI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2525891985","title":"SCIENTURE announces the divestiture of its legacy subsidiaries for a total consideration of $5 million and dedicates its full focus to the Branded and Specialty Pharma segment through Scienture, LLC.","url":"https://stock-news.laohu8.com/highlight/detail?id=2525891985","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525891985?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:05","pubTimestamp":1744113900,"startTime":"0","endTime":"0","summary":"TAMPA, FL, April 08, 2025  -- SCIENTURE HOLDINGS, INC.  , a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, announced the divestiture of its legacy Healthcare IT and Wholesale Operations subsidiaries Integra Pharma Solutions , Bonum Health, Inc., and Softell, Inc. to Tollo Health, Inc. for a total consideration of $5 million.The divestitures are part of a broader strategic realignment at the Company designed to sharpen operational focus and unlock long-term value. It is aligned with the Company’s commitment to streamline its core operations, optimize its portfolio, and accelerate growth in the Branded and Specialty Pharma markets. The Company intends to use the proceeds obtained from the divestment to facilitate the high-growth commercial and strategic product development a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scienture-announces-divestiture-legacy-subsidiaries-120500992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4167","IPS","SCNX"],"gpt_icon":0},{"id":"2525020755","title":"BRIEF-Scienture Holdings Files Prospectus Relates To Resale From Time To Time Of Up To 2.6 Million Shares Of Common Stock By Selling Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2525020755","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525020755?lang=en_us&edition=fundamental","pubTime":"2025-04-05 05:59","pubTimestamp":1743803954,"startTime":"0","endTime":"0","summary":"BRIEF-Scienture Holdings Files Prospectus Relates To Resale From Time To Time Of Up To 2.6 Million Shares Of Common Stock By Selling StockholdersApril 4  - Scienture Holdings Inc SCNX.O:SCIENTURE HOLDINGS FILES PROSPECTUS RELATES TO RESALE FROM TIME TO TIME OF UP TO 2.6 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERSSource text: [ID:n0001641172-25-002814]Further company coverage: SCNX.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250404:nFWN3QI1L7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2525753960","title":"Scienture files to sell 2.64M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2525753960","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525753960?lang=en_us&edition=fundamental","pubTime":"2025-04-05 05:15","pubTimestamp":1743801346,"startTime":"0","endTime":"0","summary":"17:13 EDT Scienture (SCNX) files to sell 2.64M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-files-to-sell-2-64m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-files-to-sell-2-64m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2524251913","title":"Scienture CEO says focused on execution, growth, expansion for years ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2524251913","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524251913?lang=en_us&edition=fundamental","pubTime":"2025-04-03 20:36","pubTimestamp":1743683806,"startTime":"0","endTime":"0","summary":"SCIENTURE (SCNX) HOLDINGS provided an annual update from CEO, Surendra Ajjarapu, to its stockholders, which read in part, “This time last year, Sci...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-ceo-says-focused-on-execution-growth-expansion-for-years-ahead?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-ceo-says-focused-on-execution-growth-expansion-for-years-ahead?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2524251140","title":"Scienture Holdings, Inc. Issues Annual Letter to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2524251140","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524251140?lang=en_us&edition=fundamental","pubTime":"2025-04-03 20:26","pubTimestamp":1743683160,"startTime":"0","endTime":"0","summary":"TAMPA, FL, April 03, 2025  -- SCIENTURE HOLDINGS, INC.  a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, is pleased to provide this annual update from its Chief Executive Officer, Surendra Ajjarapu, to its stockholders.Scienture, LLC  was founded in June 2019 as a branded specialty pharmaceutical company with a mission to address critical gaps in patient care by challenging treatment paradigms, product safety and efficacy limitations, access and adherence hurdles, to deliver better patient solutions. It is committed to creating value by developing robust in-house platforms, acquiring or in-licensing differentiated products and nuanced commercialization, that address the needs of patients and caregi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scienture-holdings-inc-issues-annual-122600011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2522881894","title":"Scienture appoints Rath as CCO, enters agreement with Syneos","url":"https://stock-news.laohu8.com/highlight/detail?id=2522881894","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522881894?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:37","pubTimestamp":1742927874,"startTime":"0","endTime":"0","summary":"Scienture (SCNX) announces Michele Rath as Senior Vice President and Chief Commercial Officer, CCO, of Scienture. Under Rath’s leadership, Scientur...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-appoints-rath-as-cco-enters-agreement-with-syneos?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-appoints-rath-as-cco-enters-agreement-with-syneos?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","LU2249611893.SGD","LU0823414551.USD","CCO","LU2506951792.HKD","LU2294711713.HKD","SCNX","LU0823414478.USD","BK4009","LU2357125470.USD"],"gpt_icon":0},{"id":"2522883027","title":"SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization","url":"https://stock-news.laohu8.com/highlight/detail?id=2522883027","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522883027?lang=en_us&edition=fundamental","pubTime":"2025-03-25 20:05","pubTimestamp":1742904300,"startTime":"0","endTime":"0","summary":"TAMPA, FL, March  25, 2025  (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on provid","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/25/3048696/0/en/SCIENTURE-Announces-Commercial-Operations-Leadership-and-Strategic-Agreement-with-Syneos-Health-a-leading-Contract-Sales-Organization.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823414478.USD","LU2294711713.HKD","BK4167","CCO","BK4009","LU2249611893.SGD","LU2506951792.HKD","LU2357125470.USD","SCNX","LU0823414551.USD"],"gpt_icon":0},{"id":"2520186925","title":"Scienture announces draaw on Equity Line of Credit","url":"https://stock-news.laohu8.com/highlight/detail?id=2520186925","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520186925?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:16","pubTimestamp":1742386586,"startTime":"0","endTime":"0","summary":"SCIENTURE (SCNX) HOLDINGS has completed a draw on its Equity Line of Credit to support the commercial launch of Arbli Oral Suspension, while simult...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-announces-draaw-on-equity-line-of-credit?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-announces-draaw-on-equity-line-of-credit?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","SCNX","BK4167","EQR","BK4215","BK4588"],"gpt_icon":0},{"id":"2520418354","title":"Scienture Holdings Inc - to Launch Arbli in U.S. in Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520418354","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520418354?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:05","pubTimestamp":1742385909,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q20CV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2520183515","title":"Scienture Holdings Announces Draw on Eloc, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2520183515","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520183515?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:05","pubTimestamp":1742385909,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q20CV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2520671951","title":"Scienture Says US FDA Approves Oral Liquid Formulation of Hypertension Drug Losartan","url":"https://stock-news.laohu8.com/highlight/detail?id=2520671951","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520671951?lang=en_us&edition=fundamental","pubTime":"2025-03-18 21:03","pubTimestamp":1742303008,"startTime":"0","endTime":"0","summary":"Scienture  said Tuesday the US Food and Drug Administration approved its new drug application for Arbli, an oral suspension formulation of hypertension drug losartan potassium.The company said Arbli is indicated for hypertension in patients older than 6 years old, stroke risk reduction in patients with hypertension and left ventricular hypertrophy, and diabetic nephropathy in certain patients with type 2 diabetes.The company also said the product has two patents and is expected to be listed in the FDA's Orange Book.Scienture said it plans to launch Arbli in the US in Q3.Shares of the company were up more than 24% in recent Tuesday premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2520627073","title":"Scienture Announces the U.S. FDA Approval of Its Nda for Scn-102, to Be Launched as Arblitm, (Losartan Potassium) Oral Suspension, 10Mg/Ml. the Global Market for Losartan Potassium Was Approximately $1.5 Billion in Sales in 2024.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520627073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520627073?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:05","pubTimestamp":1742299500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nTUAV7TGK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2520026627","title":"Scienture Holdings Inc - Arbli Expected to Be Available in U.S. in Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520026627","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520026627?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:05","pubTimestamp":1742299500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nTUAV7TGK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2519615248","title":"Scienture Holdings Inc - Appoints Eric Sherb as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2519615248","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519615248?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:28","pubTimestamp":1741897696,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nFWN3PW1N2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2517216456","title":"BUZZ-U.S. STOCKS ON THE MOVE-CoreCivic, Teladoc, Dynavax","url":"https://stock-news.laohu8.com/highlight/detail?id=2517216456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517216456?lang=en_us&edition=fundamental","pubTime":"2025-03-06 23:41","pubTimestamp":1741275681,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-CoreCivic, Teladoc, DynavaxEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL3N3PP1CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561818.USD","VG","CXW","IE00BJTD4N35.SGD","LU1496350171.SGD","LU2023250843.SGD","IE00BKVL7J92.USD","SCNX","ZS","LU1699723380.USD","LU0648001328.SGD","LEN","FCX","TDOC","BURL","LU1267930573.SGD","MRVL","DHI","HUT","PHM","ALGM","CZR","IBRX","FAST","IE00BJTD4V19.USD","LULU","MDB","NEM","VSCO","BK4543","LU1366192091.USD","CPB","BAC","DVAX","KBH","BTSG","LU0149725797.USD","HTGC","MOS","LU1223082196.USD","BK4560","LU2552382215.SGD","KR","SPRY"],"gpt_icon":1},{"id":"2517610151","title":"Scienture Unit, Summit Biosciences Collaborate to Launch Naloxone Spray for Opioid Overdose Treatment in the US","url":"https://stock-news.laohu8.com/highlight/detail?id=2517610151","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517610151?lang=en_us&edition=fundamental","pubTime":"2025-03-06 23:37","pubTimestamp":1741275457,"startTime":"0","endTime":"0","summary":"Scienture (SCNX) said Thursday its Scienture LLC unit signed an agreement with Summit Biosciences for the exclusive rights to commercially launch Rezenopy, a 10mg naloxone HCl nasal spray for opioid o","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SCNX","BK4211","BK4167","SMMF"],"gpt_icon":0},{"id":"2517163239","title":"Scienture Holdings Shares up 45.7% on Launch of Opioid Overdose Antidote Rezenopy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517163239","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517163239?lang=en_us&edition=fundamental","pubTime":"2025-03-06 22:32","pubTimestamp":1741271559,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP115:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2517168920","title":"BUZZ-U.S. STOCKS ON THE MOVE-Scienture, ARS Pharma, BrightSpring Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2517168920","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517168920?lang=en_us&edition=fundamental","pubTime":"2025-03-06 22:09","pubTimestamp":1741270157,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Scienture, ARS Pharma, BrightSpring HealthEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call new","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e5c43d65b893d390fb338910195c4df7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL6N3PP0KV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTSG","LU0330918003.SGD","IE00BBT3K403.USD","IE00BZ1G4Q59.USD","BURL","LU0719512351.SGD","IE00BMPRXN33.USD","IBRX","LU0971096721.USD","BAC","MDB","LU2498475776.HKD","LU2089284900.SGD","IE00B64PRP62.GBP","LU1506573853.SGD","ZS","LU2237438978.USD","BK4560","LU0788109121.HKD","ALGM","LU2125909916.SGD","LU0320765489.SGD","FCX","LU2471134523.USD","LU1989764748.USD","LU0708994859.HKD","LU1883839398.USD","LU2028103732.USD","LU1244550577.SGD","IE00B7SZLL34.SGD","BK4604","KKR","CPB","LU2756315318.SGD","LU0048584097.USD","NEM","LU2430703251.USD","SPRY","LU0082616367.USD","LU1914381329.SGD","LU2750360997.AUD","LU0648001328.SGD","SCNX","VSCO","IE00BHPRN162.USD","LU2237443978.SGD","LU2360107168.USD","LU1732800096.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCNX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"SCNX","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.33},{"market":"US","date":"2025-03-26","symbol":"SCNX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-11-06","symbol":"SCNX","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":-1.34},{"market":"US","date":"2024-08-09","symbol":"SCNX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":null},{"date":"2024-07-19","symbol":"SCNX","amount":1.5,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-07-19","defaultRemindTime":1721395800000,"name":"Trxade Group, Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-24","payableDate":"2024-07-19","currency":"USD","dateTimestamp":1721361600000,"payDate":"2024-07-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCNX\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-25","recordDate":"2024-03-18","paymentDate":"2024-03-22","value":8,"currency":"USD"},{"executeDate":"2024-07-19","recordDate":"2024-07-19","paymentDate":"2024-07-24","value":1.5,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCNX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SCNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SCNX","date":"2025-07-11","current":-1.411087,"percent":0.096447,"low":-4.335221,"twenty":-0.813268,"median":1.154073,"eighty":2.262758,"high":3.580326,"avg":0.630941,"sd":1.976359,"marketCap":21510943},"quantilePoints":[{"date":"2024-09-27","current":-0.598388,"twenty":-0.613397,"median":-0.60738,"eighty":-0.601331,"marketCap":10677383},{"date":"2024-10-04","current":-0.575439,"twenty":-0.613397,"median":-0.603293,"eighty":-0.596854,"marketCap":10267882},{"date":"2024-10-11","current":-0.569717,"twenty":-0.610449,"median":-0.596691,"eighty":-0.575112,"marketCap":10165786},{"date":"2024-10-18","current":-3.316594,"twenty":-3.320439,"median":-0.603293,"eighty":-0.579563,"marketCap":59179885},{"date":"2024-10-25","current":-3.532893,"twenty":-3.381003,"median":-0.61388,"eighty":-0.587997,"marketCap":63039443},{"date":"2024-10-31","current":-3.835472,"twenty":-3.470407,"median":-1.920019,"eighty":-0.593421,"marketCap":68438535},{"date":"2024-11-08","current":-3.92083,"twenty":-3.680939,"median":-3.316594,"eighty":-0.596527,"marketCap":69961625},{"date":"2024-11-15","current":3.401097,"twenty":-3.547313,"median":-1.920019,"eighty":-0.574948,"marketCap":68584767},{"date":"2024-11-22","current":3.456572,"twenty":-3.511744,"median":-0.611468,"eighty":3.395976,"marketCap":69703464},{"date":"2024-11-29","current":3.136519,"twenty":-3.477174,"median":-0.603293,"eighty":3.362691,"marketCap":63249440},{"date":"2024-12-06","current":3.110915,"twenty":-3.463831,"median":-0.596691,"eighty":3.285878,"marketCap":62733118},{"date":"2024-12-13","current":3.337086,"twenty":-3.450219,"median":-0.582313,"eighty":3.360949,"marketCap":67293962},{"date":"2024-12-20","current":3.469375,"twenty":-3.422821,"median":-0.572987,"eighty":3.384019,"marketCap":69961625},{"date":"2024-12-27","current":2.837803,"twenty":-3.405517,"median":1.134043,"eighty":3.366915,"marketCap":57225683},{"date":"2025-01-03","current":2.561875,"twenty":-3.372831,"median":2.613767,"eighty":3.343052,"marketCap":51661454},{"date":"2025-01-10","current":2.200068,"twenty":-3.341588,"median":2.571818,"eighty":3.331965,"marketCap":44365450},{"date":"2025-01-17","current":1.983099,"twenty":-3.320439,"median":2.304552,"eighty":3.323431,"marketCap":39990159},{"date":"2025-01-24","current":1.820372,"twenty":-3.285831,"median":2.061208,"eighty":3.308922,"marketCap":36708691},{"date":"2025-01-31","current":1.69236,"twenty":-3.231997,"median":1.995032,"eighty":3.279477,"marketCap":34127269},{"date":"2025-02-07","current":1.431997,"twenty":-2.180107,"median":1.896311,"eighty":3.250031,"marketCap":28876920},{"date":"2025-02-14","current":1.375585,"twenty":-0.618263,"median":1.823627,"eighty":3.227841,"marketCap":27739344},{"date":"2025-02-21","current":1.184652,"twenty":-0.615326,"median":1.76613,"eighty":3.213059,"marketCap":23889088},{"date":"2025-02-28","current":1.145598,"twenty":-0.611128,"median":1.69236,"eighty":3.194897,"marketCap":23101536},{"date":"2025-03-07","current":1.045792,"twenty":-0.608474,"median":1.646775,"eighty":3.193463,"marketCap":21088902},{"date":"2025-03-14","current":0.538084,"twenty":-0.602312,"median":1.540482,"eighty":3.184314,"marketCap":10850721},{"date":"2025-03-21","current":0.733356,"twenty":-0.598212,"median":1.425488,"eighty":3.168951,"marketCap":14788483},{"date":"2025-03-28","current":0.715999,"twenty":-0.597181,"median":1.375585,"eighty":3.16127,"marketCap":14438460},{"date":"2025-04-04","current":1.435684,"twenty":-0.595056,"median":1.425488,"eighty":3.153589,"marketCap":13015619},{"date":"2025-04-11","current":1.12784,"twenty":-0.589891,"median":1.375585,"eighty":3.136519,"marketCap":10224770},{"date":"2025-04-17","current":1.246836,"twenty":-0.582313,"median":1.328698,"eighty":3.136519,"marketCap":11303565},{"date":"2025-04-25","current":1.311304,"twenty":-0.575439,"median":1.30873,"eighty":3.110915,"marketCap":11888016},{"date":"2025-05-02","current":1.325247,"twenty":-0.574621,"median":1.311304,"eighty":3.085311,"marketCap":12014418},{"date":"2025-05-09","current":1.290735,"twenty":-0.571352,"median":1.304933,"eighty":2.846338,"marketCap":11701542},{"date":"2025-05-16","current":-0.774291,"twenty":-0.575439,"median":1.297499,"eighty":2.837803,"marketCap":11803474},{"date":"2025-05-23","current":-0.765773,"twenty":-0.597508,"median":1.28756,"eighty":2.645772,"marketCap":11673621},{"date":"2025-05-30","current":-0.779626,"twenty":-0.610109,"median":1.27693,"eighty":2.645772,"marketCap":11884796},{"date":"2025-06-06","current":-0.894836,"twenty":-0.730719,"median":1.246836,"eighty":2.594563,"marketCap":13641086},{"date":"2025-06-13","current":-0.959367,"twenty":-0.765773,"median":1.225767,"eighty":2.581761,"marketCap":14624818},{"date":"2025-06-20","current":-0.856031,"twenty":-0.771761,"median":1.212713,"eighty":2.569829,"marketCap":13049535},{"date":"2025-06-27","current":-0.841318,"twenty":-0.780624,"median":1.184652,"eighty":2.512356,"marketCap":12825244},{"date":"2025-07-03","current":-1.247608,"twenty":-0.792738,"median":1.179469,"eighty":2.409427,"marketCap":19018822},{"date":"2025-07-11","current":-1.411087,"twenty":-0.813268,"median":1.154073,"eighty":2.262758,"marketCap":21510943}],"updateTime":1752507298928}}}